Amyris, Inc., a leader in the development and production of sustainable, fermentation-derived ingredients in the markets...
Nuance Biotech, a China-based specialty pharmaceutical company, has announced Series B fundraising of US$20 million with...
Ascletis BioScience Co., Ltd. and CR Pharmaceutical Commercial Group Co., Ltd. have jointly announced that the two parti...
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and delivery of high quality, cost-...
OUE Lippo Healthcare Limited (OUELH) has announced that its joint venture company with leading Chinese state-owned congl...
Chinese bio-pharmaceutical developer, manufacturer and marketer of oncology drugs Tot Biopharm recently a...
Alibaba Group Holding Ltd. is selling its medical assets for HK$10.6 billion ($1.4 billion) to a Hong Kong-listed unit t...
Alpha Biopharma Inc has announced the first $37 million closing of its $65 million Series A financing led by Q...
Pacira Pharmaceuticals, Inc. and Nuance Biotech Co. Ltd have entered into an agreement with Nuance, a China based specia...
The research team of Hong Kong Baptist University (HKBU) has invented a medical device with a specific nanotechnology la...
WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions fo...
Bristol Myers Squibb recently announced that the China National Drug Administration (CNDA) has approved ...
AIDS remains an incurable disease. In the world, HIV/AIDS has resulted in estimated 40 million deaths while 36.9 million...
Aptose Biosciences Inc., a clinical-stage biotechnology company committed to developing personalized therapies addressin...
Parkinson’s disease is one of the leading neural degenerative disorders which is primarily caused by death of dopa...
Yaoshibang, a Guangzhou-based online pharmacy trading and education platform, recently completed a RMB420 million ($65.7...
